FIBROSING CHOLESTATIC HEPATITIS AND HBV AFTER BONE-MARROW TRANSPLANTATION

被引：23

作者：

COOKSLEY, WGE

MCIVOR, CA

机构：

[1] Clinical Research Centre, Royal Brisbane Hospital Foundation, Bancroft Centre, Post Office Royal Brisbane Hospital, Brisbane, Queensland

来源：

BIOMEDICINE & PHARMACOTHERAPY | 1995年 / 49卷 / 03期

关键词：

FIBROSING CHOLESTATIC HEPATITIS; HEPATITIS B VIRUS; BONE MARROW TRANSPLANTATION;

D O I：

10.1016/0753-3322(96)82604-7

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Liver failure caused by reactivation of hepatitis B virus (HBV) is an uncommon complication of bone marrow transplantation. Fibrosing cholestatic hepatitis is a recently described liver lesion that develops in some patients undergoing liver transplantation for chronic HBV infection. The lesion is characterised by peri portal fibrosis, ballooning degeneration of hepatocytes, prominent cholestasis and paucity of inflammation. Recent data suggests it is a cytopathic effect of the pre-core mutant form of HBV with over-expression of viral antigens. Although only one case has so far been described associated with bone marrow transplantation (BMT) it is likely that increasing use of BMT in people with chronic HBV infection will lead to further patients being recognised.

引用

页码：117 / 124

页数：8

共 59 条

[1] COMBINATION ANTIVIRAL THERAPY CONTROLS SEVERE POST-LIVER TRANSPLANT RECURRENCE OF HEPATITIS-B VIRUS-INFECTION [J].

ANGUS, P ;

RICHARDS, M ;

BOWDEN, S ;

IRETON, J ;

SINCLAIR, R ;

JONES, R ;

LOCARNINI, S .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (04) :353-357

[2] HEPATITIS-B VIRUS PRECORE MUTANT INFECTION IS ASSOCIATED WITH SEVERE RECURRENT DISEASE AFTER LIVER-TRANSPLANTATION [J].

ANGUS, PW ;

LOCARNINI, SA ;

MCCAUGHAN, GW ;

JONES, RM ;

MCMILLAN, JS ;

BOWDEN, DS .

HEPATOLOGY, 1995, 21 (01) :14-18

[3]

BIRD GLA, 1989, Q J MED, V270, P895

[4] HEPATITIS-B VIRUS-DNA IN THE SERA OF HBSAG-CARRIERS - A MARKER OF ACTIVE HEPATITIS-B VIRUS-REPLICATION IN THE LIVER [J].

BONINO, F ;

HOYER, B ;

NELSON, J ;

ENGLE, R ;

VERME, G ;

GERIN, J .

HEPATOLOGY, 1981, 1 (05) :386-391

[5] HEPATITIS-B VIRUS HETEROGENEITY, ONE OF MANY FACTORS INFLUENCING THE SEVERITY OF HEPATITIS-B [J].

BONINO, F ;

BRUNETTO, MR .

JOURNAL OF HEPATOLOGY, 1993, 18 (01) :5-8

[6] WILD-TYPE AND E-ANTIGEN-MINUS HEPATITIS-B VIRUSES AND COURSE OF CHRONIC HEPATITIS [J].

BRUNETTO, MR ;

GIARIN, MM ;

OLIVERI, F ;

CHIABERGE, E ;

BALDI, M ;

ALFARANO, A ;

SERRA, A ;

SARACCO, G ;

VERME, G ;

WILL, H ;

BONINO, F .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4186-4190

[7]

BRUNETTO MR, 1989, ITAL J GASTROENTEROL, V21, P151

[8]

CALMUS Y, 1989, Q J MED, V270, P895

[9]

CARMAN WF, 1989, LANCET, V2, P588

[10] CHANGING OF HEPATITIS-B VIRUS MARKERS IN PATIENTS WITH BONE-MARROW TRANSPLANTATION [J].

CHEN, PM ;

FAN, S ;

LIU, CJ ;

HSIEH, RK ;

LIU, JH ;

CHUANG, MW ;

LIU, RS ;

TZENG, CH .

TRANSPLANTATION, 1990, 49 (04) :708-713

← 1 2 3 4 5 6 →